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destructive potential for nasal mucosa. There is a correlation between upper airway inﬂammation
and COPD exacerbation suggesting that the nose may be used to model the lung in COPD, but the
relationship between organisms colonizing the upper and lower respiratory tracts is not clear.
Aim of work: The aim of this study was to identify the individual bacterial cultures in nasal swab
and BAL and to correlate these microbiological data in patients with CRS and concomitant COPD
exacerbation.
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82 H. Aref et al.for the study. Pulmonary function and paranasal sinuses CT examinations were performed together
with endoscopic and clinical assessment. Endoscopic middle meatal swab and BAL were done to all
subjects. All the specimens were examined for aerobic and anaerobic bacteria.
Results: Nasal swab cultures revealed 49.2% Gram positive organisms, 34.9% Gram negative
organisms, and anaerobes 15.9%, BAL cultures resulted in 44.5% Gram positive organisms,
46% Gram negative organisms, and anaerobes 9.5%. Streptococcus pneumoniae was predominant
in both nasal swab and BAL (25.3% and 26.9%, respectively) followed by Staphylococcus aureus
(23.8% and 17.4%) Moraxella catarrhalis (15.8% and 20.6%), haemophilus inﬂuenza (14.2%
and 19%) and Pseudomonas aeruginosa (4.3% and 6.3%). Matched organisms between upper
and lower respiratory tract cultures were seen in 41 (65%) subjects.
Conclusion: Aerobic bacteria were the predominant organisms cultured from both upper and lower
airways in chronic sinusitis patients with acute exacerbation of chronic bronchitis. The matched
pattern of microorganisms cultured concomitantly from upper and lower airways, may suggest that
nasal swab can be used as a non-invasive tool to predict lower airway pathogens.
ª 2011 Egyptian Society of Ear, Nose, Throat and Allied Sciences.
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Cigarette smoke is the most important risk factor for COPD.
It has a destructive potential for nasal mucosa, it is a cause
of the pathological signs of mucosal inﬂammation,1 it may
cause several nasal symptoms,2 impairment of mucociliary
function,3 and other changes.4 These changes may even hap-
pen with second hand smoking.5 Chronic rhinosinusitis is a
group of disorders characterized by inﬂammation of the muco-
sa of the nose and paranasal sinuses of at least 12 weeks
duration.6
Exacerbations of chronic obstructive pulmonary disease
(COPD) were regarded as having a little impact on the course
of COPD. In the last decade, new research methods have been
applied to this question that have led to a better delineation of
the contribution of bacterial infection to exacerbations of
COPD.7 Much of the morbidity, mortality, hospital admission,
and health care cost in COPD relate to episodes of acute
COPD exacerbations.8
Interactions between the upper and lower airways have
been extensively studied in patients with asthma. In contrast,
little is known about possible upper airway involvement in
COPD patients, in whom cigarette smoke provides the pan-
airway exposure in contrast to the allergen stimulation of
allergic disease. Recently studies pointed to the correlation
between upper and lower respiratory affection and related
severity of upper airway involvement to that present in the
lower airway, suggesting that the nose may be used to model
the lung in COPD.9
There is no universally accepted deﬁnition of an exacerba-
tion of COPD. The typical symptoms of exacerbation include
breathlessness, cough, increased sputum production and puru-
lence, wheeze and chest tightness. Although usually clinicians
have little difﬁculty in diagnosing an exacerbation of COPD,
establishing a universally accepted deﬁnition for epidemiolog-
ical or interventional studies has proved difﬁcult. The most
widely used deﬁnition has been symptom-based.10
The predominant mechanism of bacterial exacerbation in
COPD appears to be acquisition of new strains of bacterial
pathogens from the environment that are able to establish
infection in the tracheobronchial tree in COPD because of
compromised innate lung defenses.11 Potential pathways bywhich bacteria could contribute to the pathogenesis of acute
exacerbation of COPD include: primary infection of the lower
airways, secondary infection of the airways after an antecedent
viral infection, and bacterial antigens inducing bronchial
hyperreactivity and eosinophilic inﬂammation, and as the
upper airways are commonly affected by chronic rhinosinusitis
in acute exacerbations, there are no studies speciﬁcally examin-
ing interrelationships between bacterial pathogens in the upper
and lower airways.
An exacerbation associated with purulent sputum produc-
tion will be associated with a large bacterial load while an
exacerbation associated with cold or upper respiratory symp-
toms will be viral in origin.12
Sputum culture was the mainstay of bacterial pathogen iden-
tiﬁcation in COPD exacerbations. Sputum is expectorated and
then subjected to microscopy and culture. A direct causal rela-
tionship between bacteria isolated from sputum and exacerba-
tion remains unproven because this technique is limited by
difﬁculty in expectoration, potential contamination with upper
airway secretions, and the presence of lower airway cells, which
can lead a pathologist to consider a good sample contaminated.
A further complication is that approximately 20–40% of
patients with COPD will have positive cultures when clinically
stable13 thus, identiﬁcation of a bacterial pathogen on stan-
dard sputum culture does not distinguish between preexisting
colonization and new infective agent. Bronchoscopy, biopsy,
and bronchoalveolar lavage (BAL) can be performed safely
in patients with COPD, including those with severe disease,
provided careful assessment is performed and guidelines are
adhered to.14
2. Patients and methods
Patients with chronic bronchitis exacerbations and chronic rhi-
nosinusitis (CRS) entered in this study. They all had chronic pro-
ductive cough formore than 3 months for two consecutive years.
The patients included in the study either had mild or moderate
airway obstruction and with irreversible or partially reversible
airway obstruction. COPDwas deﬁned as a post-bronchodilator
forced expiratory volume in one second (FEV1) to forced vital
capacity ratio <70% and a ß2-agonist reversibility on predicted
FEV1 of <15% or 200 ml. Exacerbation was conﬁrmed by the
Nasal swab as an alternative to bronchoscopic lavage for identiﬁcation of pathogenic organisms in patients 83worsening of at least one of the three cardinal symptoms of exac-
erbation: dyspnoea, sputum volume and purulence.
All patients have chronic rhinosinusitis as proved by at
least 3 months of symptoms of facial pain or pressure, nasal
obstruction or blockage, nasal discharge or purulence or dis-
colored postnasal drainage, hyposmia or anosmia. Chronic
rhinosinusitis was conﬁrmed by the presence of middle meatus
secretions seen at the nasal endoscopy and paranasal sinuses
opacity seen at coronal CT scan cuts according to Lund and
Mackay scoring system, patients with deviated nasal septum
which impairs the visualization of middle meatus were
excluded from the study. Exclusion criteria included other
causes of chronic cough and expectoration, such as bronchiec-
tasis, tuberculosis, lung cancer, occupational or other exposure
to substances known to cause lung disorders, congenital or ac-
quired systemic immunodeﬁciency; therapy with antimicrobial
agents within 3 weeks before entry into the study, and CO2
retention (Pco2 > 45 mmHg) or evidence of cor pulmonale.
Patients with severe irreversible airway obstruction were
excluded from the study because of safety issues.
In total, 63 patients were recruited for the study and 10
subjects with CRS and normal lower airways were taken as a
control group. Patients were recruited by a selection of patients
having chronic rhinosinusitis during chronic bronchitis exacer-
bation. At recruitment, patients’ daily respiratory symptoms,
smoking history, COPD exacerbation history and drug history
were recorded. Height and weight were measured, in addition
to baseline lung function and reversibility to ß2-agonists was
measured after inhaling 400 lg salbutamol from a metered-
dose inhaler. The ethics committee of the hospital approved
the study, and all patients gave an informed consent. Patients
recruited to this study were subjected to middle meatal swab
and bronchoalveolar lavage in same sitting, samples were sent
for aerobic and anaerobic bacteriological cultures.
2.1. Middle meatus swab
The middle meatus swab for bacterial culture was done with the
patient in a sitting position, cotton containing vasoconstrictor
(oxymethazolin) and an anesthetic (4% cocaine) was placed
along the lower nasal turbinate for 5 min. Nasal endoscopy
was performed with 30 wide angle, 2.7 mm rigid endoscope
(Storz). A swab was passed into the middle meatus under endo-
scopic guidance and directed to the site of mucopurulent dis-
charge. In those patients who had previously undergone sinus
surgery, the swab was passed directly into the maxillary or eth-
moid cavity. The swab was left in place for few seconds until
moistened and then it was carefully removed. The samples were
collected using two swabs per patient. All specimens for aerobic
culture were obtained with a collection swab (BBL Culture
Swab [Cat #220099], for anaerobic culture specimens were
collected by BD BBL Collection and Transport Systems, BBL
Vacutainer [Cat #236500]. The swabs were transferred to Stuart
transport media and sent immediately for aerobic microbiolog-
ical examination. The Vacutainer provides a moist anaerobic
atmosphere for anaerobic bacterial culture.
2.2. Bronchoalveolar lavage
Fiberoptic bronchoscopy (model 1T10 bronchoscope;
Olympus; Tokyo, Japan) with inspection of bronchial mucosaand of all segmental bronchi was performed in all patients.
Bronchoalveolar lavage was performed by instilling 150 ml
of sterile saline solution, in three 50-ml aliquots, through the
ﬁbreoptic bronchoscope wedged into the lobe selected for
lavage (usually middle lobe or lingual). The lavage ﬂuid was
then recovered by gentle suction after each aliquot had been
infused. The total amounts of ﬂuid recovered were recorded.
2.3. Blood sample
A 5-ml sample of venous blood was collected into a sterile
Vacutainer, centrifuged, and analyzed for complete blood
picture, ESR and CRP.
2.4. Microbiological examination
The samples were forwarded to the laboratory at most 1 h
after collection. Quantitative cultures were processed accord-
ing to the standard laboratory protocol and Gram staining
was performed on 1 drop of undiluted BAL ﬂuid. All samples
were mechanically liquiﬁed and homogenized by vortexing for
1 min with glass beads, centrifuged at 3000 rpm for 10 min.
The samples were then serially diluted in 0.9% sterile saline
solution with ﬁnal dilutions of 102, 103 and 104 according
to the standard laboratory protocol. All swabs and BAL spec-
imens plated as following.
2.4.1. For aerobic bacterial cultures
The specimens were inoculated directly onto Mac Conkey,
10% Sheep Blood agar media, Chocolate Bacitracin blood
agar, Gentamycin blood agar, Mannitol salt agar and Thayer
Martin (contain vancomycin to inhibit Gram positive bacteria
and colistin to inhibit Gram negative bacteria). All plates were
incubated at 37 C for 24 h in the aerobic and CO2 incubators
depending on the media inoculated. If there was no bacterial
growth, the medium was re incubated for 24 h more before it
was released as negative.15
2.4.2. For anaerobic bacterial cultures
The specimens were inoculated on Sheep Blood agar, Neomy-
cin anaerobic blood agar, Bacteroide Bile Esculine agar, Brain
Heart Infusion agar and tube of thioglycollate broth as soon as
possible. All plates were placed in an OXOID GasPak jar
(2.5 l) with AnareoGen (Oxide AN 23) for rapid generation
of anaerobic environments which was essential for rapid
growth of fastidious organisms. Incubate at 35 C for 48 h.
The thioglycollate broth tubes were incubating at 35 C. All
organisms isolated were subcultured on blood agar media
and incubated aerobically and anaerobically. We selected all
strict anaerobes. If direct cultures were negative after 48 h
incubation, we repeated subcultured from thioglycollate broth
on fastidious anaerobe blood agar and neomycin agar. All
plates were incubated anaerobically for an additional 48 h. If
cultures were negative, report out as negative after 4 days
incubation. If no growth was detected after 96 h, the original
plates were reported to be negative.15,16
We deﬁned our cases as having microbiological evidence of
bronchoscopic BAL samples that grew one or more respira-
tory pathogens at a diagnostic threshold of P104 cfu/ml3.
Growth below the threshold was assumed to be due to
Table 1 Clinical characteristics of patients with chronic rhinosinusitis during COPD exacerbation (63 patients) compared with a
control group of patients with chronic rhinosinusitis (10 patients) without lower respiratory tract affection.
Clinical
characteristics
Chronic rhinosinusitis
with COPD exacerbation
(n= 63)
Chronic
rhinosinusitis
(n= 10)
Age, yr Maximum 71 65
Minimum 39 38
Mean ± SD 54 ± 7 48.5 ± 7.8
Sex Males 43 7
Females 20 3
Smoking status Smokers 41 4
Ex-smokers 22 0
Non-smokers 0 6
Smoking pack/year Maximum 50 22
Minimum 14 0
FEV1% predicted Maximum 78 102
Minimum 50 82
Mean ± SD 64 ± 6.3 88 ± 6.9
FEV1/FVC ratio (%) Maximum 69 88
Minimum 47 75
Mean ± SD 59 ± 6.3 81.5 ± 3.7
WBC ·103 ll1 Maximum 20.5 9.4
Minimum 5.8 4.1
Mean ± SD 13.2 ± 2.8 5.85 ± 1.7
Neutrophil count (%) Maximum 96 77
Minimum 47 48
Mean ± SD 76 ± 12.0 55.5 ± 8.4
CRP mg/dl Maximum 176 11
Minimum 9 4.2
Mean ± SD 30 ± 47 7.1 ± 2.1
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thresholds for the diagnosis were as follows: >10 polymor-
phonuclear neutrophils (PMN)/high-power ﬁeld (HPF), 1 bac-
teria/oil immersion ﬁeld (OIF), presence of intracellular
bacterial inclusions. All organisms were identiﬁed by standard
bacteriological methods. After isolation and conﬁrmation of
Gram positive and negative bacteria by Gram stain, Potential
pathogens present at P1 · 104 CFU/ml were considered clini-
cally signiﬁcant,17 and identiﬁcation as following:
2.4.3. Biochemical micro tests
n API 20E test (bioMe´rieux, Marcy l’Etoile, France), which
was used to identify Gram-negative bacteria of Enterobac-
teriaceae family and other fermenting Gram-negative rods
and API 20NE test (bioMe´rieux, Marcy l’Etoile, France)
to identify non-fermenting Gram-negative rods.
n GP2 MicroPlate test (BIOLOG, Inc., Hayward, CA, USA)
were used to determine Gram-positive bacteria. It was
identiﬁed by standard methods, including Gram stain,
measurement of catalase production, results of a slide
agglutination test (Staphaurex; Murex Biotech Limited),
and results of a tube coagulase test .The tube coagulase test,
plasma was inoculated with suspicious colonies and exami-
nation of tubes after incubation for 4 h and 24 h. Oxacillin
resistance for each Staphylococcus aureus isolate was deter-mined by measuring growth on Mueller Hinton agar (MH)
containing 4% NaCl and 6 lg/ml oxacillin, as recom-
mended by the Clinical Laboratory Standards Institute.18
Other identiﬁcation tests as Streptex rapid latex test
(Remel), Streptex for use in the qualitative identiﬁcation
of the Lanceﬁeld group of Streptococci, optochin disk
(Oxide) for identiﬁcation of Streptococcal pneumoniae, fac-
tor X, V, & XV discs for identiﬁcation of Haemophilus spp.
were also used as well according to types of isolates.
2.4.4. Carbohydrate utilization tests
n Cystine-trypticase agar (CTA) basal medium with phenol
red containing ﬁlter sterilized glucose, maltose, lactose,
and sucrose was used to identify the classically pathogenic
Moraxella catarrhalis. A heavy inoculum of a pure culture,
no more than 24 h old, was stab inoculated into the upper
half of the CTA. Tubes are incubated without added CO2
at 35C. After 24 h the upper portion of the tubes are
observed for acid. No acid from any of the four sugars.15
n All anaerobic microorganisms grown were identiﬁed by
standard bacteriological methods. It was identiﬁed by its
colonial and microscopic morphology, growth on selective
media, oxygen tolerance, and biochemical characteristics.
These included sugar fermentation, bile solubility, esculin,
Figure 1 Comparison of cultured organisms from bronchoscopic lavage to nasal swab samples during COPD exacerbation from patients
with combined chronic rhinosinusitis and COPD.
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catalase, lipase, lecithinase, and indole production and
nitrate reduction, its identiﬁcation was made with the use of
the API system for anaerobic germs (Bio Merieux,
France).16,19Figure 2 Comparison of organisms from nasal swab and
bronchoscopic lavage in the control group (10 subjects), four
subjects did not show bacterial growth in bronchoscopic lavage
and three subjects revealed S. viridians nonpathogenic subtype,
whereas all the nasal swab cultures showed pathogenic organisms.2.4.5. Automated identiﬁcation systems
VITEK2 (bioMe´rieux, Marcy l’Etoile, France), had been
introduced. VITEK 2 cards (NGPC; bioMe´rieux, REF.
21341) for identiﬁcation of Gram-positive cocci and (GN bio-
Me´rieux, REF.21342) for identiﬁcation of Gram-negative ba-
cilli were used. Suspensions were prepared by emulsifying
puriﬁed bacterial isolates in 0.45% saline to the equivalent of
a 0.5 McFarland turbidity standard. Suspensions for the com-
parative identiﬁcation method were made according to the
manufacturer’s recommendations.20,21
3. Results
The baseline clinical characteristics of the 63 (43 males and 20
females) patients studied at exacerbation are reported in Table
1 and compared with a control group (10 patients) of patients
with chronic rhinosinusitis (7 males and 3 females) 4 of them
were current smokers and 6 were non smokers and none of
them ex-smokers. Subjects in the control group were similar
to the exacerbation group as regards the sex and age
distribution.
Subjects in the control population were of similar age and
sex distribution to those of the exacerbation of COPD pa-
tients, but had a higher total nonsmokers and the total pack/
year rate is lower, also the forced expiratory volume in the ﬁrst
second (FEV1) percentage of predicted and the FEV1/FVC ra-
tio were higher in the control group, whereas the WBC counts,
neutrophil percentage and CRP were higher in the exacerba-
tion group.
3.1. Comparison between bacteria cultured from nasal swab and
bronchoscopic lavage
The overall rate for aerobic Gram positive organisms cul-
tured from the nasal swab was 49.2% and the aerobic Gram
negative organisms was 34.9% and the remaining 15.9%
anaerobes, in the BAL cultures the overall rate for aerobic
Gram positive organisms 44.5% and 46% were aerobicGram negative organisms and the remaining 9.5% were
anaerobes.
The bacterial subtype that was retrieved in cultures from
the nasal swab and bronchoscopic lavage was summarized in
Fig. 1 and it showed that S. pneumoniae were cultured from
17 bronchoscopic lavage ﬂuid compared with 16 samples of
nasal swab (26.9% vs 25.3%) where as S. aureus was cultured
from 11 bronchoscopic lavage samples compared to 15 nasal
swab samples (17.4% vs 23.8%). The ﬁnding of higher M.
catarrhalis cultures in 13 samples (20.6%), Haemophilus in-
ﬂeunzae cultures in 12 samples (19%) and Pseudomonas aeru-
ginosa cultures in 4 samples (6.3%) from the bronchoscopic
lavage compared to that of nasal swab samples 10 samples
(15.8%), 9 samples (14.2%) and 3 samples, (4.7%) respec-
tively. The nasal swab cultures showed a higher percentage
of anaerobic growth in 10 samples (15.8%) compared to bron-
choscopic lavage, 6 samples (9.5%).
In the control group (10 patients) there was no growth in 4
samples of the bronchoscopic lavage (40%) and 3 cases
showed growth of nonpathogenic Streptococcus viridians
(30%), 1 case ofS. pneumoniae (10%) and 2 cases ofH. inﬂeun-
zae. The nasal swab of the control group showed growth in the
10 samples, 4 of them showed anaerobic growth (40%) and 3
cases showed S. pneumoniae (30%) 1 case of M. catarrhalis
(10%) and 2 cases of H. inﬂeunzae (20%) (see Fig. 2).
Figure 4 Percentages of matched pathogens cultured from nasal
swab compared with lower respiratory pathogens retrieved from
bronchoalveolar lavage. The column (100%) stands for the
number of organisms cultured from the nasal swab; the darker
color indicates the percentage of that cultured organism matched
with BAL culture for each patient.
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cultures
The nasal swab results were studied individually for the
dominant organism and compared to results from the
bronchoscopic lavage and there were 41 (65%) cases showing
matched growth (i.e., similar organism subtypes was retrieved
from both upper and lower airways) whereas 22 cases (35%)
showed unmatched bacterial growth and the cultures from na-
sal swab and bronchoscopic lavage retrieved different organ-
isms, Conﬁdence Interval (CI) of the matched cultures was
0.52, in the control group there was no matching of bacterial
growth in all samples (see Fig. 3).
3.3. The percentages of nasal swab organisms matched to BAL
cultures
On comparing the results of culture between nasal swab and
BAL for each patient; all the three cases of P. aeruginosa cul-
tured from nasal swab (100%) were found to match to results
of the BAL ﬂuid whereas cases with nasal swab S. pneumoniae
were 9 out of 16 cases (56.2%), S. aureus cases were 11 out of
15 (73.3%),M. catarrhalis cases were 8 out of 10 (80%),H. in-
ﬂeunzae cases were 7 out of 9 (77.7%) and anaerobes cases
were 2 out of 10 cases (20%) (see Fig. 4).
4. Discussion
In this study, we performed middle meatal swab and broncho-
alveolar lavage under local anesthesia on the same sitting for
patients with chronic rhinosinusitis and concomitant chronic
bronchitis exacerbation. Chronic obstructive pulmonary dis-
ease (COPD) is a condition characterized by an abnormal
inﬂammatory response in the lung to noxious particles or
gases. The exacerbation of COPD may also be associated with
increased upper airway inﬂammation.22 There is growing
evidence of pan-airway involvement in chronic obstructive
pulmonary disease.23Figure 3 Comparison between the matched and unmatched
bacterial growth in nasal swab and bronchoscopic lavage in
chronic rhinosinusitis patients with COPD exacerbation. There
was no matching growth between the nasal and bronchoscopic
samples in the control group.Kim and Rubin23 in their review stated that concomitant
sinonasal disease is probably under diagnosed and under trea-
ted in patients with COPD and they suggested that therapy di-
rected toward treating the upper airway is likely to improve the
health status of patients with lower airway disease. In addition,
smokers who complain of nasal or sinus symptoms should al-
ways be evaluated for concomitant lower airway disease.23
We hypothesized the possibility of lower respiratory tract
infection transmitted from the upper airway passages in pa-
tients with chronic rhinosinusitis.
With the current interest into the united airway disease and
development of medications that target the infection in both
sites, there is a need for clinically applicable procedure for
obtaining samples for culture can be relied upon. This is the
ﬁrst study to simultaneously sample the upper airway through
middle meatal swab, lower airway through bronchoscopic la-
vage at exacerbation of COPD.
In our study, the aerobic bacteria comprised the majority of
both the nasal swab and BAL cultures (84.1% and 90.5%,
respectively). There is higher percentage of anaerobes in the
nasal swab specimens compared to BAL specimens. Initial
studies by Frederick and Braude24 in the 1970s implicated
polymicrobial pathogens and emphasized the importance of
anaerobes in paranasal sinuses cultures. More recent studies,
however, have downplayed the role of anaerobes in paranasal
sinuses culture results (anaerobes accounted for [less than] 6%
of isolates in most series) and have implicated Staphylococcus
and Streptococcus spp. as major pathogens.25 Some of these
authors have suggested that the inconsistencies in reporting
are the result of variations in culture techniques and the fastid-
ious nature of anaerobes. Aerobic organisms were 49.2%
Gram positive in the nasal swab results and lower respiratory
tract BAL were less (44.5%) meanwhile the Gram negative
aerobic organisms in BAL culture were higher (46% compared
to 34.9% in nasal swab results).
We used the method of endoscopic middle meatal swab as
it gained increasing popularity, easy to perform, has low
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tion with antral puncture cultures which is relatively morbid,
painful to the patient and is difﬁcult for the clinician to per-
form in an outpatient setting.26
Our ﬁndings of a signiﬁcant correlation between microbio-
logical culture results from upper and lower airways in patients
with concomitant chronic rhinosinusitis and COPD exacerba-
tion provide new insight into the assessment of the sinonasal
condition in COPD patients.
Hurst et al.22 in their study on sputum examination and
nasal wash concluded that a relationship between lower air-
way bacterial colonization and both higher nasal bacterial
load and postnasal drip may suggest a possible mechanism
for cross-talk between the upper and lower airways in COPD
patients, although that study was conducted on sputum exam-
ination and it is not the optimum method to study the lower
airway inﬂammation, and they did not examine the condition
during the COPD exacerbation. Another study conducted by
Hurst et al.27 in another study on sputum and nasal wash dur-
ing COPD exacerbation concluded that there was a relation-
ship between upper and lower airway inﬂammation and
COPD exacerbation is associated with pan-airway inﬂamma-
tion and he studied the bacterial load in both sites.
In our study we were concentrating on the microbiological
relation of organisms that colonize the upper airways in
chronic rhinosinuitis and its impact on acquisition of COPD
exacerbation and we found that there was a matched growth
between upper and lower airways verifying that there is a cau-
sal relation.
Ragab et al.28 in their study on intubated patients with
chronic rhinosinusitis and different types of airway diseases
that did not include COPD exacerbation revealed that
aerobic Gram-positive bacteria were the most commonly cul-
tured bacteria (70%) in the middle meatus of CRS while our
results showed that aerobic gram positive cultures in both
the nasal swab and BAL cultures were 49.2% and 34.9%,
respectively,
The result of matched bacterial growth in the upper and
lower airways in our study (65%) was signiﬁcant to support
the hypothesis that the nose can be used to model the lung
in COPD although the calculated 95% conﬁdence interval
(CI) for that matched group was 0.52 which may affect the sen-
sitivity of the nasal swab as a diagnostic tool to predict the
lower airway pathogens, which may be attributed to the small
number of patients entered in this study as it was difﬁcult to
recruit larger group of patients during their acute exacerba-
tion. It is recommended to try the study on a larger scale of pa-
tients to identify the validity of our results.
The matched growth of P. aeruginosa in nasal and BAL
cultures points to the possibility of acquisition of the organism
and the occurrence of exacerbation resulted from short term
colonization of the lower respiratory tract rather than chronic
colonization, while the unmatched percent in the anaerobic
bacterial colonization was high.
5. Conclusion
Aerobic bacteria were the predominant organisms cultured
from both upper and lower airways in chronic sinusitis
patients with acute exacerbation of chronic bronchitis. There
was observed matched pattern of microorganisms culturedconcomitantly from upper and lower airways, although it
did not reach high statistical signiﬁcance, but may suggest
that nasal swab may be used as a non-invasive tool to pre-
dict lower airway pathogens and recommending larger group
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